Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)

Summary

This 39-week, active controlled, study is designed to assess long-term efficacy, safety and tolerability of lumiracoxib 100mg od in patients with osteoarthritis (OA) of the knee who participated in the 13-week core CCOX189A2361 study.

Timeline

Start

2003-12

Primary completion

2004-11

Completion

—

Drugs

Indications